Arkolith/Insider Trading/FBIO/Form 4

Weiss Michael S

See Remarks, DirectorFortress Biotech, Inc. (FBIO) · full profile →Form 4 · filed Nov 16, 2023
Net Buying
Open-Market Buys
$250K
Open-Market Sells
$0
Net Open-Market Flow
$250K
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 14, 2023Buy(P)147K$1.70$250K1.1M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 14, 2023Buy(P)147K—$0147K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-23-119186) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML